Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease

Nandini Venkateswaran,1 Yandong Bian,1 Preeya K Gupta2 1Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA; 2Triangle Eye Consultants, Cary, NC, USACorrespondence: Preeya K Gupta, Email preeyakgupta@gmail.comAbstract: Dry eye disease (DED) is a prevalent ocular surface dise...

Полное описание

Библиографические подробности

Главные авторы:	Venkateswaran N, Bian Y, Gupta PK
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Dove Medical Press 2022-02-01
Серии:	Clinical Ophthalmology
Предметы:	dry eye disease dry eye disease flares loteprednol etabonate 0.25% mucus penetrating particle technology ocular surface inflammation
Online-ссылка:	https://www.dovepress.com/practical-guidance-for-the-use-of-loteprednol-etabonate-ophthalmic-sus-peer-reviewed-fulltext-article-OPTH
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!